Difference between revisions of "User:Cecilia Cisar/Notebook/Mod 3 Research Proposal"

From OpenWetWare
Jump to: navigation, search
(Overview)
Line 5: Line 5:
  
 
==Overview==
 
==Overview==
* During certain stages of growth, cancer cells exhibit unique miRNA signatures.<cite>Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.</cite>
+
* During certain stages of growth, cancer cells exhibit unique miRNA signatures.<ref>Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.</ref>
  
* Some organisms use miRNA to target and inhibit sections of bacterial DNA.<cite>Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.</cite>
+
* Some organisms use miRNA to target and inhibit sections of bacterial DNA.<ref>Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.</ref>
  
 
==References==
 
==References==

Revision as of 15:08, 5 May 2014

Project Description/Abstract

  • To design bacteria that use specific miRNA signatures to target cancer cells.

Overview

  • During certain stages of growth, cancer cells exhibit unique miRNA signatures.[1]
  • Some organisms use miRNA to target and inhibit sections of bacterial DNA.[2]

References

  1. Calin, George A., and Carlo M. Croce. "MicroRNA signatures in human cancers." Nature Reviews Cancer 6.11 (2006): 857-866.
  2. Ma, Feng, et al. "The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]."Nature immunology 12.9 (2011): 861-869.
Recently Edited Notebook Pages